Rchr
J-GLOBAL ID:201701008624905662   Update date: Sep. 28, 2024

Kato Hiroyuki

Kato Hiroyuki
Affiliation and department:
Job title: associate professor
Research field  (1): Experimental pathology
Research theme for competitive and other funds  (5):
  • 2021 - 2024 肺胞マクロファージの炎症調節機能に着目した重症型慢性肺疾患の病態解明
  • 2020 - 2023 膵癌における腫瘍内DPD発現抑制化合物併用による新規5-FU療法確立への基盤研究
  • 2019 - 2022 去勢抵抗性前立腺癌に対する新規免疫療法の確立に目指した腫瘍免疫機構の解明
  • 2019 - 2022 Interaction between hepatocytes and stellate cells in NASH
  • 2017 - 2020 Chemopreventive effect of anti-allergy drug as drug-repositioning on pancreatic carcinogenesis
Papers (70):
  • Asraful Nahar Sheema, Aya Naiki-Ito, Anna Kakehashi, Omnia Hosny Mohamed Ahmed, David B Alexander, William T Alexander, Takamasa Numano, Hiroyuki Kato, Yuko Goto, Hiroshi Takase, et al. Fullerene and fullerene whisker are not carcinogenic to the lungs and pleura in rat long-term study after 2-week intra-tracheal intrapulmonary administration. Archives of toxicology. 2024
  • Hiroyuki Kato, Motonori Sato, Aya Naiki-Ito, Shingo Inaguma, Makoto Sano, Masayuki Komura, Yuko Nagayasu, Kuang Xiaochen, Akihisa Kato, Yoichi Matsuo, et al. The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer. Cancer medicine. 2024. 13. 16. e70124
  • Aya Naiki-Ito, Ranchana Yeewa, Kuang Xiaochen, Weerakit Taychaworaditsakul, Taku Naiki, Hiroyuki Kato, Yuko Nagayasu, Teera Chewonarin, Satoru Takahashi. Hexane insoluble fraction from purple rice extract improves steatohepatitis and fibrosis via inhibition of NF-κB and JNK signaling. Food & function. 2024
  • Yuki Denda, Yoichi Matsuo, Keisuke Nonoyama, Hiromichi Murase, Tomokatsu Kato, Yuichi Hayashi, Hiroyuki Imafuji, Kenta Saito, Mamoru Morimoto, Hiroyuki Kato, et al. Simultaneous presentation and resection of esophageal cancer and metastasis to the pancreas: Α case report and literature review. Molecular and clinical oncology. 2024. 20. 1. 2-2
  • Akiko Kato, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Mitsuo Terada, Hiroyuki Kato, Masayuki Komura, et al. Low TINAGL1 expression is a marker for poor prognosis in breast cancer. Journal of cancer research and clinical oncology. 2023. 149. 8. 4771-4782
more...
MISC (14):
  • 伊藤 直, 稲熊 真悟, 小川 了, 小村 理行, 加藤 寛之, 内木 綾, 齋藤 正樹, 上野 修平, 早川 俊輔, 大久保 友貴, et al. 膵癌におけるテトラスパニンCD63の発現と臨床的意義. 日本外科学会定期学術集会抄録集. 2023. 123回. SF-1
  • Taku Naiki, Aya Naiki-Ito, Hiroyuki Kato, Keitaro Iida, Toshiki Etani, Yuko Nagayasu, Shugo Suzuki, Yoriko Yamashita, Takahiro Yasui, Satoru Takahashi. MIR-8080 RECRUITMENT INHIBITS EXPRESSION OF ANDROGEN RECEPTOR SPLICING VARIANTS IN CASTRATION-RESISTANT PROSTATE CANCER. JOURNAL OF UROLOGY. 2020. 203. E218-E218
  • A case of rapidly-growing infundibulocystic basal cell carcinoma of the scalp. 2019. 73. 13. 1099-1103
  • Kato, Hiroyuki, Yamashita, Yoriko, Suzuki, Shugo, Naiki-Ito, Aya, Takahashi, Satoru. CD44 as an invasion marker for encapsulated papillary carcinioma of the breast. CANCER SCIENCE. 2018. 109. 976-976
  • Naiki-Ito, Aya, Kato, Hiroyuki, Suzuki, Shugo, Yamashita, Yoriko, Takahashi, Satoru. Connexin 32 prevents the development of insulin resistance and hepatocarcinogenesis in non-alcoholic steatohepatitis. CANCER SCIENCE. 2018. 109. 380-380
more...
Professional career (1):
  • 博士 (名古屋市立大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page